Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
429.20    -13.10 (-2.96%)
Bid:
428.10
Ask:
428.40
Spread: 0.30 (0.07%)
Market Cap: £10.80b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

2 Apr 2020 13:36

RNS Number : 6127I
Rentokil Initial PLC
02 April 2020
Β 

Rentokil Initial plc

2 April 2020

Β 

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

Β 

Rentokil Initial plc (the "Company") hereby announces that the award granted under the Rentokil Initial plc Performance Share Plan (PSP) in March 2017 for John Myers (a person discharging managerial responsibility) of 153,277 shares has been released with 56,848 of these shares subsequently being sold at a share price of Β£3.6216 to cover his tax and social security liability.

The Company further announces that Chris Hunt (a person discharging managerial responsibility) has today purchased 2,708 ordinary shares in the Company at a price of Β£3.67 per share.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

John Myers

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Managing Director, North America

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Rentokil Initial plc

b)

Β 

LEI

Β 

549300VN4WV7Z6T14K68

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 1p each

Β 

Β 

ISIN: GB00B082RF11

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Release of awards made under the 2017 Performance Share Plan (PSP)

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β 

Nil consideration

Β 

153,277

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

153,277 shares

Β 

-

Β 

e)

Β 

Date of the transaction

Β 

31 March 2020

f)

Β 

Place of the transaction

Β 

Outside a trading venue

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

John Myers

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Managing Director, North America

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Rentokil Initial plc

b)

Β 

LEI

Β 

549300VN4WV7Z6T14K68

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 1p each

Β 

Β 

ISIN: GB00B082RF11

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Sale of shares to cover the tax and social security liability arising following the release of an award made under the 2017 Performance Share Plan (PSP).

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β 

Β£3.6216

Β 

56,848

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Aggregated price

Β 

- Total

Β 

Β 

Β 

56,848 shares

Β 

Β£3.6216

Β 

Β£205,880.72

e)

Β 

Date of the transaction

Β 

1 April 2020

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

a)

Β 

Name

Β 

Chris Hunt

Β 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Group M&A Director (PDMR)

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Β 

Name

Β 

Rentokil Initial plc

b)

Β 

LEI

Β 

549300VN4WV7Z6T14K68

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 1p each

Β 

Β 

ISIN: GB00B082RF11

b)

Β 

Nature of the transaction

Β 

Purchase of shares

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£3.67

2,708

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Aggregated price

Β 

- Total

Β 

Β 

Β 

2,708

Β 

Β£3.67

Β 

Β£9,938.36

e)

Β 

Date of the transaction

Β 

2 April 2020

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

Enquiries:

Β 

Daragh Fagan, Company Secretary Rentokil Initial plc 01276 607444

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHBDGDSXXGDGGD
Date   Source Headline
25th Nov 20193:25 pmRNSHolding(s) in Company
14th Nov 20194:00 pmRNSHolding(s) in Company
8th Nov 20195:30 pmRNSHolding(s) in Company
8th Nov 20199:40 amRNSDirector/PDMR Shareholding
6th Nov 20195:00 pmRNSHolding(s) in Company
5th Nov 20195:10 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSAcquisition of Florida Pest Control, USA
31st Oct 20194:30 pmRNSDirector/PDMR Shareholding
17th Oct 20197:00 amRNS3rd Quarter Trading Update
30th Sep 201910:20 amRNSBlock listing Interim Review
23rd Sep 201910:30 amRNSHolding(s) in Company
13th Sep 20194:00 pmRNSDirector/PDMR Shareholding
19th Aug 20193:15 pmRNSDirector/PDMR Shareholding
5th Aug 20191:58 pmRNSDirector/PDMR Shareholding
31st Jul 20197:00 amRNSInterim Results
23rd Jul 20197:00 amRNSAppointment of Joint Corporate Broker
2nd Jul 201910:35 amRNSPost Stabilisation Notice
21st Jun 20197:00 amRNSDirectorate Change
11th Jun 201912:00 pmRNSHolding(s) in Company
31st May 20195:00 pmRNSHolding(s) in Company
30th May 20195:00 pmRNSDirector Declaration
17th May 20194:04 pmRNSDirector/PDMR Shareholding
15th May 20199:30 amRNSPre Stabilisation Notice
8th May 20192:30 pmRNSResult of AGM
29th Apr 201911:40 amRNSDirector/PDMR Shareholding
18th Apr 20197:00 amRNSQ1 Trading Update
12th Apr 20196:25 pmRNSDirector/PDMR Shareholding - Replacement
11th Apr 20194:37 pmRNSDirector/PDMR Shareholding
10th Apr 20191:57 pmRNSDirector Declaration
1st Apr 20197:00 amRNSBlock listing Interim Review
29th Mar 20197:00 amRNSTotal Voting Rights
27th Mar 201911:18 amRNSAnnual Financial Report
25th Mar 20199:58 amRNSDirector/PDMR Shareholding
12th Mar 201912:17 pmRNSDirector/PDMR Shareholding
6th Mar 20192:00 pmRNSAdditional Listing
6th Mar 20191:05 pmRNSDirector/PDMR Shareholding
1st Mar 20197:00 amRNSInnovative good causes initiative
28th Feb 20195:15 pmRNSDirector/PDMR Shareholding
28th Feb 20197:05 amRNSDirectorate Changes and Appointment of Chairman
28th Feb 20197:00 amRNSFinal Results
15th Feb 20195:15 pmRNSHolding(s) in Company
1st Feb 20197:00 amRNSChange to Director's details
4th Dec 20187:00 amRNSDefined benefit pension scheme buy-in with PIC
20th Nov 20185:17 pmRNSHolding(s) in Company
16th Nov 20184:14 pmRNSHolding(s) in Company
24th Oct 20182:36 pmRNSDirector/PDMR Shareholding
18th Oct 20187:00 amRNSQ3 Trading Update
2nd Oct 201812:17 pmRNSBlock listing Interim Review
25th Sep 20187:25 amRNSDirector Declaration
13th Sep 20184:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.